ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Otonomy Inc

Otonomy Inc (OTIC)

0.077
0.00
(0.00%)
Closed 25 November 8:00AM
0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.077
Bid
0.0757
Offer
0.0777
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.077
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

OTIC Latest News

Otonomy Announces Change in Stock Exchange Listing

SAN DIEGO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC) today announced that it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (Nasdaq...

Otonomy Provides Corporate Update

SAN DIEGO, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC) today announced that the company’s board of directors, after considering strategic options, has approved and adopted a...

Otonomy Reports Third Quarter 2022 Financial Results and Provides Corporate Update

SAN DIEGO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today reported...

Otonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss

Higher dose cohorts for OTO-413 demonstrated no clinically meaningful improvement for patients from baselineLack of activity compared to 0.3 mg dose evaluated in prior studies may be due to a...

Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus

OTO-313 demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepointsCompany to discontinue development of OTO-313 and implement other...

Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Top-line results for OTO-313 Phase 2 trial in tinnitus expected in August 2022; patient enrollment completed for clinical safety evaluation of higher and bilateral dosing of OTO-313 with top-line...

Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate Update

SAN DIEGO, July 18, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...

Otonomy to Participate in the H.C. Wainwright Global Investment Conference

SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced its...

Otonomy Announces OTO-825 Presentation at the American Society of Gene & Cell Therapy Annual Meeting

SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...

Otonomy Reports First Quarter 2022 Financial Results and Provides Corporate Update

Positive top-line results announced for OTO-413 Phase 2a in hearing loss; enrollment ongoing for higher dose evaluationOTO-313 Phase 2 trial in tinnitus fully enrolled with top-line results...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PDYNPalladyne AI Corporation
US$ 4.59
(129.50%)
83.07M
QMCOQuantum Corporation
US$ 9.11
(126.62%)
39.48M
NANano Labs Ltd
US$ 8.26
(89.02%)
2.03M
XCURExicure Inc
US$ 18.60
(71.27%)
4.59M
SKKSKK Holdings Limited
US$ 1.75
(59.09%)
107.47M
AMIXAutonomix Medical Inc
US$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
US$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
US$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
US$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
US$ 0.0201
(-0.50%)
425.38M
NVDANVIDIA Corporation
US$ 141.95
(-3.22%)
236.51M
SMCISuper Micro Computer Inc
US$ 33.15
(11.62%)
159.61M
VRPXVirpax Pharmaceuticals Inc
US$ 0.5501
(-6.72%)
159.39M
SOUNSoundHound AI Inc
US$ 8.24
(18.05%)
107.91M

Discussion

View Full Feed
3331 3331 5 minutes ago
BIEL (Bioelectronics): #5 BREAKOUT BOARD + #5 MOST READ (last hour)!
blackhawks blackhawks 6 minutes ago
Hey Trump Voters .........

https://i.postimg.cc/sxY6Q0K0/IMG-4787.jpg
blackhawks blackhawks 7 minutes ago
Hey Trump Voters .........

https://i.postimg.cc/sxY6Q0K0/IMG-4787.jpg
MysticCentaur11 MysticCentaur11 7 minutes ago
https://yougotsmarter.com/best-fishing-partner-gifts/ Bump.
pos_stock_hoarder pos_stock_hoarder 8 minutes ago
A great idea! The BEE stings again.
dinogreeves dinogreeves 9 minutes ago
Schwab just halted borrows on SMCI. Lets see in the morning if this has any merits.
SMCI
leverage102 leverage102 11 minutes ago
I may jump in tomorrow.

Thanks
SFIO
Turbomunkey Turbomunkey 12 minutes ago
3 more weeks of this and youre going to see me on the evening news.
NXPL
dinogreeves dinogreeves 14 minutes ago
VCNX is getting marinated and prepped for a major run. How fast and far up, all depends on what the insiders motives are. The science is one of the best breeds out there. This could fly to 20 dollars and still be cheap. Hands down the next DRU*G in the making and even higher in the triple dollar
VCNX
mrfence mrfence 15 minutes ago
$FMCC~ $FNMA~
[yt]ojULkWEUsPs?si=8v4gJoCdDPdl5068[/yt]
FMCC FNMA
TucsonPhil TucsonPhil 15 minutes ago
Halted after 4pm on Friday, before FDA approval news.

Should spike on Monday!
BBIO
umtiti umtiti 16 minutes ago
https://forums.garmin.com/developer/connect-iq/f/showcase/393304/new-updated-how-to-get-free-dice-on-monopoly-go-ultimate-guide-to-monopoly-go-free-dice-november-2024
https://forums.garmin.com/developer/connect-iq/f/showcase/393316/updated-new-750-free-shein-gift-cards---how-to-get-free-shein
aheadofthecurve aheadofthecurve 16 minutes ago
I'm clueless buddy. I don't get it.
I tell ya though I've seen a lot of articles or publishing etc since they've gone EM
RSPI
arizona1 arizona1 16 minutes ago
So many police and military. Everywhere.

I think we're about to relive it. This is what white MAGA wants.
gp22 gp22 17 minutes ago
$VVOS @ $3.13: Microfloat. Cash rich. Recent FDA Approval of only device for Sleep Apnea. Upgraded last week to $6.00 Valuation.
Coming off lows on elevated volume last week. Likely moves very nicely in coming sessions
VVOS
gdl gdl 17 minutes ago
investing.com-- U.S. stock index futures rose in evening deals on Sunday as Wall Street appeared to be relieved by President-elect Donald Trump nominating prominent investor Scott Bessent as Treasury Secretary.

Futures were buoyed by a persistent rotation into cyclical and economical
LLY
aheadofthecurve aheadofthecurve 18 minutes ago
I agree. 
RSPI
splintered sunlight splintered sunlight 18 minutes ago
YES!!!!!!!!!!!!
CHYI
gp22 gp22 18 minutes ago
$VVOS @ $3.13: Microfloat. Cash rich. Recent FDA Approval of only device for Sleep Apnea. Upgraded last week to $6.00 Valuation.
Coming off lows on elevated volume last week. Likely moves very nicely in coming sessions.
VVOS
Mr Smith 34 Mr Smith 34 19 minutes ago
Nice try skippy.
Maybe those terms you Googled can buff most, but that dog don't hunt with me.
Maybe a few community college classes could help you out.
(and I think the term you were looking for is an arm chair quarterback)
SPZI
umtiti umtiti 19 minutes ago
wow
XRPUSD
tradedays1224 tradedays1224 20 minutes ago


CIVX
mrwilson31 mrwilson31 20 minutes ago
Great post! 
XCRT
Werbe Werbe 20 minutes ago
What's up with investing in real companies, building generational wealth?  Oh whateva
CNNA

Your Recent History

Delayed Upgrade Clock